--- title: "Medinotec (MDNC) stock listing, news and investor profile" url: "https://aibio.space/companies/medinotec/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Medinotec Inc. (OTC: MDNC), United States. Listing facts, related biotech companies and news on aibio.space." --- MDNC Medinotec Inc. OTC · United States # Medinotec (MDNC) news Medinotec Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker MDNC, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Medinotec news We have not published a story on Medinotec yet. When there is news, it will appear here. ## Medinotec at a glance - **Ticker**: MDNC - **Listing**: OTC - **Country**: United States - **Cash, Aug 31, 2026**: $2.6 million ### Related companies - [Nyxoah SA](https://aibio.space/companies/nyxoah/) NASDAQ: NYXH - [PACIFIC BIOSCIENCES OF CALIFORNIA, INC.](https://aibio.space/companies/pacific-biosciences-of-california/) NASDAQ: PACB - [Adagio Medical Holdings](https://aibio.space/companies/adagio-medical/) NASDAQ: ADGM - [TRAFALGAR INTERNATIONAL, INC.](https://aibio.space/companies/trafalgar-international-gcand/) OTC: GCAND - [Canopy Growth](https://aibio.space/companies/canopy-growth/) NASDAQ: CGC - [Opthea](https://aibio.space/companies/opthea/) OTC: CKDXF - [NEXGEL, INC.](https://aibio.space/companies/nexgel/) NASDAQ: NXGL - [ZIMMER BIOMET HOLDINGS, INC.](https://aibio.space/companies/zimmer-biomet/) NYSE: ZBH ### Also on OTC - [Cannamerica Brands](https://aibio.space/companies/cannamerica-brands/) CNNXF - [ESCALON MEDICAL CORP](https://aibio.space/companies/escalon-medical/) ESMC - [PONIARD PHARMACEUT](https://aibio.space/companies/poniard-pharmaceut/) PARD - [Neutra](https://aibio.space/companies/neutra/) NTRR - [Leef Brands](https://aibio.space/companies/leef-brands/) LEEEF - [Zeo ScientifiX](https://aibio.space/companies/zeo-scientifix/) ZEOX ## What Medinotec does Medinotec Inc. operates through the Medinotec Group of Companies, whose operating subsidiary, DISA Medinotec Proprietary Limited, manufactures in Johannesburg, South Africa. The group generates revenue from two sources: internally designed and manufactured proprietary medical devices, and distribution of third-party medical products under exclusive or non-exclusive agreements in defined territories. Its proprietary products include the Trachealator, a non-occlusive airway dilation balloon, the Outflo Aortic Valve Dilation Balloon Catheter, and the Cape Cross family of PTCA balloon catheters. The group also distributes cardiology and renal dialysis products from multinational manufacturers, primarily in South Africa. Its distributor arrangements cover South Africa, Namibia, Mauritius, the Middle East, Europe, South America and portions of Asia. The Trachealator received FDA 510(k) clearance in November 2021 and Outflo received clearance in March 2025, and the company has taken steps to develop sales channels in the United States. As of February 28, 2026, the group had 48 employees and independent contractors. | Product or program | What it is | Stage | |---|---|---| | Trachealator | Non-occlusive airway dilation balloon | FDA 510(k) clearance November 2021 | | Outflo Aortic Valve Dilation Balloon Catheter | Aortic valve dilation balloon catheter | FDA 510(k) clearance March 2025 | | Cape Cross PTCA balloon catheters | Family of PTCA balloon catheters | | Summarised from the company's [10-K filed May 28, 2026](https://www.sec.gov/Archives/edgar/data/1931055/000166357726000175/mdnc_10k022826.htm). ## Medinotec annual financials | Line | FY ended Feb 28, 2026 | FY ended Feb 28, 2025 | |---|---|---| | Revenue | [$9.7 million](https://www.sec.gov/Archives/edgar/data/1931055/000166357726000175/) | [$9.1 million](https://www.sec.gov/Archives/edgar/data/1931055/000166357726000175/) | | Research and development | [$149,858](https://www.sec.gov/Archives/edgar/data/1931055/000166357726000175/) | [$91,133](https://www.sec.gov/Archives/edgar/data/1931055/000166357726000175/) | | Net income (loss) | [$794,502](https://www.sec.gov/Archives/edgar/data/1931055/000166357726000175/) | [$2.2 million](https://www.sec.gov/Archives/edgar/data/1931055/000166357726000175/) | | Cash from operations | [$906,798](https://www.sec.gov/Archives/edgar/data/1931055/000166357726000175/) | [$877,834](https://www.sec.gov/Archives/edgar/data/1931055/000166357726000175/) | | Cash and equivalents | [$2.8 million](https://www.sec.gov/Archives/edgar/data/1931055/000166357726000326/) | [$2.8 million](https://www.sec.gov/Archives/edgar/data/1931055/000166357726000326/) | Latest balance sheet, Aug 31, 2026 (10-Q): cash and equivalents $2.6 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Medinotec What is the ticker symbol of Medinotec? Medinotec Inc. trades under the ticker MDNC on OTC. Where is Medinotec listed? Medinotec Inc. is listed on OTC. Which country or territory is Medinotec listed under? Our directory records Medinotec Inc. under United States. Does aibio.space cover Medinotec? aibio.space lists Medinotec Inc. among 2,820 public biotech companies and publishes its news here as stories appear. What does Medinotec develop? Medinotec Inc. operates through the Medinotec Group of Companies, whose operating subsidiary, DISA Medinotec Proprietary Limited, manufactures in Johannesburg, South Africa. The group generates revenue from two sources: internally designed and manufactured proprietary medical devices, and distribution of third-party medical products under exclusive or non-exclusive agreements in defined territories. What is Trachealator from Medinotec? Trachealator: Non-occlusive airway dilation balloon Stage: FDA 510(k) clearance November 2021. What is Outflo Aortic Valve Dilation Balloon Catheter from Medinotec? Outflo Aortic Valve Dilation Balloon Catheter: Aortic valve dilation balloon catheter Stage: FDA 510(k) clearance March 2025. What was Medinotec's revenue last year? $9.7 million for the fiscal year ended Feb 28, 2026, as reported to the SEC. Is Medinotec profitable? Medinotec Inc. reported net income of $794,502 for the fiscal year ended Feb 28, 2026, and generated $906,798 of cash from operations, per its annual report to the SEC. How much does Medinotec spend on research and development? $149,858 in the fiscal year ended Feb 28, 2026, per its annual report. How much cash does Medinotec have? $2.6 million in cash at Aug 31, 2026, per its 10-Q. ## Investor discussion: Medinotec Members talk about Medinotec (MDNC). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open OTC:MDNC on TradingView](https://www.tradingview.com/symbols/OTC-MDNC/). ## Listing details Medinotec Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker MDNC, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Medinotec Inc. - **Ticker**: MDNC - **Listing**: OTC - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/medinotec/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Medinotec (MDNC) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/medinotec/